scholarly article | Q13442814 |
P50 | author | David Alan Young | Q44462616 |
John Loughlin | Q64605563 | ||
Kenneth Samora Rankin | Q87789494 | ||
P2093 | author name string | Ramsay Refaie | |
Matt J Barter | |||
Louise N Reynard | |||
Michael D Rushton | |||
P2860 | cites work | Genetics and epigenetics of osteoarthritis. | Q37972444 |
Epigenetic mechanisms in cartilage and osteoarthritis: DNA methylation, histone modifications and microRNAs. | Q37979063 | ||
Insights from human genetic studies into the pathways involved in osteoarthritis | Q38130079 | ||
cAMP response element-binding (CREB) recruitment following a specific CpG demethylation leads to the elevated expression of the matrix metalloproteinase 13 in human articular chondrocytes and osteoarthritis. | Q38326101 | ||
Expression of the osteoarthritis-associated gene GDF5 is modulated epigenetically by DNA methylation. | Q39530390 | ||
DNA demethylation at specific CpG sites in the IL1B promoter in response to inflammatory cytokines in human articular chondrocytes | Q42117977 | ||
Genome-wide DNA methylation analysis of articular chondrocytes reveals a cluster of osteoarthritic patients | Q45750089 | ||
TGF-β and osteoarthritis--the good and the bad. | Q50929726 | ||
Association between the abnormal expression of matrix-degrading enzymes by human osteoarthritic chondrocytes and demethylation of specific CpG sites in the promoter regions. | Q54638931 | ||
Identification of the pathogenic pathways in osteoarthritic hip cartilage: commonality and discord between hip and knee OA | Q63647703 | ||
The role of chondrocyte senescence in osteoarthritis | Q73711251 | ||
An update on the epidemiology of knee and hip osteoarthritis with a view to prevention | Q77093064 | ||
Expression of ADAMTS-4 by chondrocytes in the surface zone of human osteoarthritic cartilage is regulated by epigenetic DNA de-methylation | Q79676737 | ||
Distinct DNA methylomes of newborns and centenarians | Q24595040 | ||
DNA methylation profiling of human chromosomes 6, 20 and 22 | Q24607522 | ||
Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts | Q24629646 | ||
The human colon cancer methylome shows similar hypo- and hypermethylation at conserved tissue-specific CpG island shores | Q24649374 | ||
Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources | Q27860739 | ||
Extreme context specificity in differential allelic expression | Q28283127 | ||
Functions of DNA methylation: islands, start sites, gene bodies and beyond | Q29547260 | ||
Adjusting batch effects in microarray expression data using empirical Bayes methods | Q29614937 | ||
Inhibition of TGF-β signaling in mesenchymal stem cells of subchondral bone attenuates osteoarthritis | Q30540454 | ||
A data-driven approach to preprocessing Illumina 450K methylation array data | Q30620580 | ||
A role for age-related changes in TGFbeta signaling in aberrant chondrocyte differentiation and osteoarthritis | Q33873604 | ||
Identification of a central role for complement in osteoarthritis | Q34230334 | ||
Complete pipeline for Infinium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. | Q34300885 | ||
Cartilage degeneration in different human joints | Q34391408 | ||
SASP reflects senescence. | Q34945503 | ||
DNA methylation directly silences genes with non-CpG island promoters and establishes a nucleosome occupied promoter | Q35389349 | ||
Age-dependent alteration of TGF-β signalling in osteoarthritis | Q35649296 | ||
On the presence and role of human gene-body DNA methylation. | Q36050706 | ||
Pathogenesis and management of pain in osteoarthritis. | Q36070771 | ||
Cartilage matrix metabolism in osteoarthritis: markers in synovial fluid, serum, and urine | Q36335049 | ||
Regulated transcription of human matrix metalloproteinase 13 (MMP13) and interleukin-1β (IL1B) genes in chondrocytes depends on methylation of specific proximal promoter CpG sites | Q36742102 | ||
Frequent switching of Polycomb repressive marks and DNA hypermethylation in the PC3 prostate cancer cell line | Q36861718 | ||
An imprinted rheumatoid arthritis methylome signature reflects pathogenic phenotype | Q36998030 | ||
TGF-beta signaling in chondrocyte terminal differentiation and osteoarthritis: modulation and integration of signaling pathways through receptor-Smads | Q37543682 | ||
Loss of methylation in CpG sites in the NF-κB enhancer elements of inducible nitric oxide synthase is responsible for gene induction in human articular chondrocytes. | Q37609036 | ||
The role of mitochondria in osteoarthritis | Q37825773 | ||
Cancer epigenetics reaches mainstream oncology | Q37851012 | ||
P433 | issue | 9 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | osteoarthritis | Q62736 |
cartilage | Q502730 | ||
P304 | page(s) | 2450-2460 | |
P577 | publication date | 2014-09-01 | |
P1433 | published in | Arthritis & Rheumatology | Q4797636 |
P1476 | title | Characterization of the cartilage DNA methylome in knee and hip osteoarthritis | |
P478 | volume | 66 |
Q42496031 | 5-Aza-2'-deoxycytidine acts as a modulator of chondrocyte hypertrophy and maturation in chick caudal region chondrocytes in culture. |
Q91286801 | A pilot study of peripheral blood DNA methylation models as predictors of knee osteoarthritis radiographic progression: data from the Osteoarthritis Initiative (OAI) |
Q33808240 | ADAMTS and ADAM metalloproteinases in osteoarthritis - looking beyond the 'usual suspects'. |
Q49293211 | Activation of a chondrocyte volume-sensitive Cl(-) conductance prior to macroscopic cartilage lesion formation in the rabbit knee anterior cruciate ligament transection osteoarthritis model |
Q26748820 | Analysis of genetics and DNA methylation in osteoarthritis: What have we learnt about the disease? |
Q49859174 | Assessment of DNA Methylation Patterns in the Bone and Cartilage of a Nonhuman Primate Model of Osteoarthritis |
Q38942837 | Building and maintaining joints by exquisite local control of cell fate |
Q38551266 | Cartilage damage in osteoarthritis and rheumatoid arthritis--two unequal siblings |
Q26773155 | Changes in Membrane Receptors and Ion Channels as Potential Biomarkers for Osteoarthritis |
Q52983370 | Chaperonin 60 regulation of SOX9 ubiquitination mitigates the development of knee osteoarthritis. |
Q57811534 | Chromatin accessibility landscape of articular knee cartilage reveals aberrant enhancer regulation in osteoarthritis |
Q38613955 | DNA Methylation in Osteoarthritis. |
Q54974118 | DNA Methylation in Osteoarthritis: Current Status and Therapeutic Implications. |
Q92932941 | DNA hypomethylation during MSC chondrogenesis occurs predominantly at enhancer regions |
Q88726117 | DNA methylation and FoxO3a regulate PHLPP1 expression in chondrocytes |
Q41352907 | DNA methylation of the RUNX2 P1 promoter mediates MMP13 transcription in chondrocytes |
Q35816932 | DNA methylation regulates sclerostin (SOST) expression in osteoarthritic chondrocytes by bone morphogenetic protein 2 (BMP-2) induced changes in Smads binding affinity to the CpG region of SOST promoter |
Q41881337 | DNA methyltransferase 3b regulates articular cartilage homeostasis by altering metabolism. |
Q36105915 | Decoding the Regulatory Landscape of Ageing in Musculoskeletal Engineered Tissues Using Genome-Wide DNA Methylation and RNASeq. |
Q36005216 | Differential DNA methylation and expression of inflammatory and zinc transporter genes defines subgroups of osteoarthritic hip patients |
Q52901753 | Downregulation of miR-221-3p contributes to IL-1β-induced cartilage degradation by directly targeting the SDF1/CXCR4 signaling pathway. |
Q38764119 | ELF3 modulates type II collagen gene (COL2A1) transcription in chondrocytes by inhibiting SOX9-CBP/p300-driven histone acetyltransferase activity |
Q58912129 | Editorial: Is It Time for Epigenetics in Osteoarthritis? |
Q46136519 | Effects of chronic cobalt and chromium exposure after metal-on-metal hip resurfacing: An epigenome-wide association pilot study |
Q37635533 | Emerging roles for long noncoding RNAs in skeletal biology and disease |
Q37130898 | Epigenetic and microRNA regulation during osteoarthritis development |
Q36042449 | Epigenetic mechanisms underlying the aberrant catabolic and anabolic activities of osteoarthritic chondrocytes. |
Q36263516 | Epigenetic regulation of interleukin-8, an inflammatory chemokine, in osteoarthritis |
Q37733832 | Epigenetically-driven anatomical diversity of synovial fibroblasts guides joint-specific fibroblast functions. |
Q35574987 | Epigenetics and Osteoarthritis |
Q38392120 | Epigenetics of osteoarticular diseases: recent developments. |
Q28596544 | Functional Characterization of the Osteoarthritis Susceptibility Mapping to CHST11-A Bioinformatics and Molecular Study |
Q26749633 | Functional genomics in osteoarthritis: Past, present, and future |
Q33940184 | Genes involved in the osteoarthritis process identified through genome wide expression analysis in articular cartilage; the RAAK study. |
Q26852663 | Genetic contribution to osteoarthritis development: current state of evidence |
Q92628585 | Genome Engineering for Osteoarthritis: From Designer Cells to Disease-Modifying Drugs |
Q57114968 | Genome-Wide DNA Methylation Analysis during Osteogenic Differentiation of Human Bone Marrow Mesenchymal Stem Cells |
Q33833496 | Genome-Wide DNA Methylation Study Identifies Significant Epigenomic Changes in Osteoarthritic Subchondral Bone and Similarity to Overlying Cartilage |
Q50674763 | Genome-wide DNA methylation analysis of articular chondrocytes identifies TRAF1, CTGF, and CX3CL1 genes as hypomethylated in osteoarthritis. |
Q35802390 | Genome-wide DNA methylation study of hip and knee cartilage reveals embryonic organ and skeletal system morphogenesis as major pathways involved in osteoarthritis |
Q90076769 | Genome-wide analysis of DNA methylation profile identifies differentially methylated loci associated with human intervertebral disc degeneration |
Q92404925 | Genome-wide analysis of aberrant methylation of enhancer DNA in human osteoarthritis |
Q40977121 | Genome-wide mapping of DNA hydroxymethylation in osteoarthritic chondrocytes |
Q39446770 | Genomics and epigenomics in rheumatic diseases: what do they provide in terms of diagnosis and disease management? |
Q53171025 | Hypoxia-inducible factor-2α induces expression of type X collagen and matrix metalloproteinases 13 in osteoarthritic meniscal cells. |
Q37298687 | Identification of DNA methylation changes associated with disease progression in subchondral bone with site-matched cartilage in knee osteoarthritis |
Q58788904 | Identification of a novel, methylation-dependent, RUNX2 regulatory region associated with osteoarthritis risk |
Q36372904 | Identification of differentially methylated regions in new genes associated with knee osteoarthritis. |
Q64096651 | Identification of long non-coding RNAs expressed in knee and hip osteoarthritic cartilage |
Q30100430 | Increased DNA Methylation and Reduced Expression of Transcription Factors in Human Osteoarthritis Cartilage |
Q37606976 | Inflammation and epigenetic regulation in osteoarthritis |
Q52668822 | Integrating genome-wide DNA methylation and mRNA expression profiles identified different molecular features between Kashin-Beck disease and primary osteoarthritis. |
Q38615243 | Integrative epigenomics, transcriptomics and proteomics of patient chondrocytes reveal genes and pathways involved in osteoarthritis. |
Q91787941 | Interplay between genetics and epigenetics in osteoarthritis |
Q90321127 | Intraspecific and interspecific investigations of skeletal DNA methylation and femur morphology in primates |
Q36331594 | Methylation quantitative trait locus analysis of osteoarthritis links epigenetics with genetic risk |
Q47766972 | MicroRNA-218-5p as a Potential Target for the Treatment of Human Osteoarthritis |
Q52691477 | Mitochondrial DNA variation and the pathogenesis of osteoarthritis phenotypes. |
Q89495323 | Mitochondrial Genetics and Epigenetics in Osteoarthritis |
Q47104080 | New insights on the MMP-13 regulatory network in the pathogenesis of early osteoarthritis |
Q88008931 | Osteoarthritis: Epigenetic clues into the molecular basis of OA |
Q85901498 | Osteoarthritis: Epigenetics of articular cartilage in knee and hip OA |
Q38702248 | Oxidative stress and chronic inflammation in osteoarthritis: can NRF2 counteract these partners in crime? |
Q49608435 | Pathways to understanding the genomic aetiology of osteoarthritis |
Q36923747 | Phlpp1 facilitates post-traumatic osteoarthritis and is induced by inflammation and promoter demethylation in human osteoarthritis. |
Q64260627 | Recent advances in understanding the regulation of metalloproteinases |
Q90578945 | Single-cell mass cytometry reveals cross-talk between inflammation-dampening and inflammation-amplifying cells in osteoarthritic cartilage |
Q38743031 | Systems approaches in osteoarthritis: Identifying routes to novel diagnostic and therapeutic strategies |
Q41828488 | TWIST1 induces MMP3 expression through up-regulating DNA hydroxymethylation and promotes catabolic responses in human chondrocytes. |
Q47215480 | Tabetri™ (Tabebuia avellanedae Ethanol Extract) Ameliorates Osteoarthritis Symptoms Induced by Monoiodoacetate through Its Anti-Inflammatory and Chondroprotective Activities. |
Q38689354 | The Epigenomic Landscape in Osteoarthritis |
Q38888317 | The first international workshop on the epigenetics of osteoarthritis |
Q26777618 | The role of inflammation-related genes in osteoarthritis |
Q41041883 | Transcriptional associations of osteoarthritis-mediated loss of epigenetic control in articular cartilage |
Q39374245 | Why location matters - site-specific factors in rheumatic diseases. |
Search more.